166 related articles for article (PubMed ID: 21643672)
21. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
Prayson RA; Chamberlain WA; Angelov L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815
[TBL] [Abstract][Full Text] [Related]
22. Parasagittal meningiomas: follow-up review.
Colli BO; Carlotti CG; Assirati JA; Dos Santos MB; Neder L; Dos Santos AC
Surg Neurol; 2006; 66 Suppl 3():S20-7; discussion S27-8. PubMed ID: 17081848
[TBL] [Abstract][Full Text] [Related]
23. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
25. An unusual case of clear cell meningioma.
Deb P; Datta SG
J Cancer Res Ther; 2009; 5(4):324-7. PubMed ID: 20160375
[TBL] [Abstract][Full Text] [Related]
26. Clear cell meningioma with histologically aggressive appearance and clinically aggressive behavior: a case report.
Hori S; Hayashi N; Ishizawa S; Hayashi S; Sato H; Nagao S; Akioka N; Nagai S; Nishikata M; Endo S
Neuropathology; 2012 Aug; 32(4):415-9. PubMed ID: 22082299
[TBL] [Abstract][Full Text] [Related]
27. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
28. En plaque sphenoid wing meningiomas: recurrence factors and surgical strategy in a series of 71 patients.
Mirone G; Chibbaro S; Schiabello L; Tola S; George B
Neurosurgery; 2009 Dec; 65(6 Suppl):100-8; discussion 108-9. PubMed ID: 19934984
[TBL] [Abstract][Full Text] [Related]
29. Meninigiomas of the Craniocervical Junction--A Distinctive Subgroup of Meningiomas.
Dührsen L; Emami P; Matschke J; Abboud T; Westphal M; Regelsberger J
PLoS One; 2016; 11(4):e0153405. PubMed ID: 27070421
[TBL] [Abstract][Full Text] [Related]
30. Intracranial hemangiopericytomas: correlation of topoisomerase IIalpha expression with biologic behavior.
Chacko G; Chacko AG; Rajshekhar V; Muliyil JP
Surg Neurol; 2006 Jan; 65(1):11-7. PubMed ID: 16378841
[TBL] [Abstract][Full Text] [Related]
31. Clear cell meningioma: case report and review of the literature.
Oviedo A; Pang D; Zovickian J; Smith M
Pediatr Dev Pathol; 2005; 8(3):386-90. PubMed ID: 16010490
[TBL] [Abstract][Full Text] [Related]
32. Clear cell meningioma with anaplastic features: case report and review of literature.
Tong-tong W; Li-juan B; Zhi L; Yang L; Bo-ning L; Quan H
Pathol Res Pract; 2010 May; 206(5):349-54. PubMed ID: 19857933
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and treatment of intracranial chordoid meningioma: a report of 30 cases.
Wang XQ; Mei GH; Zhao L; Li ST; Gong Y; Zhong J; Chen H; Jiang CC
Histopathology; 2013 Jun; 62(7):1002-17. PubMed ID: 23617629
[TBL] [Abstract][Full Text] [Related]
34. Analysis of factors affecting the long-term functional outcome of patients with skull base meningioma.
Nakao N; Ohkawa T; Miki J; Nishibayahsi H; Ogura M; Uematsu Y; Itakura T
J Clin Neurosci; 2011 Jul; 18(7):895-8. PubMed ID: 21565513
[TBL] [Abstract][Full Text] [Related]
35. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
36. Intracranial meningiomas in children: report of 8 cases.
Alexiou GA; Mpairamidis E; Psarros A; Sfakianos G; Prodromou N
Pediatr Neurosurg; 2008; 44(5):373-5. PubMed ID: 18703882
[TBL] [Abstract][Full Text] [Related]
37. Optic nerve sheath meningiomas.
Saeed P; Rootman J; Nugent RA; White VA; Mackenzie IR; Koornneef L
Ophthalmology; 2003 Oct; 110(10):2019-30. PubMed ID: 14522782
[TBL] [Abstract][Full Text] [Related]
38. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):858-63. PubMed ID: 17379447
[TBL] [Abstract][Full Text] [Related]
40. Lipomatous meningioma: a study of five cases with brief review of literature.
Jaiswal AK; Mehrotra A; Kumar B; Jaiswal S; Vij M; Behari S; Pal L
Neurol India; 2011; 59(1):87-91. PubMed ID: 21339670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
